Sang-A Frontec Co.Ltd (089980) — Capital Reinvestment Ratio
Latest as of September 2025:
0.50x
Sang-A Frontec Co.Ltd (089980) has a Capital Reinvestment Ratio of 0.50x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩6.26 Billion) in capital expenditures (₩3.14 Billion). See Sang-A Frontec Co.Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.50x
Capex / Operating Cash Flow
Operating Cash Flow
₩6.26 Billion
KRW
Capital Expenditures
₩3.14 Billion
KRW
Data as of
Sep 2025
Most recent filing
Sang-A Frontec Co.Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks Sang-A Frontec Co.Ltd's Capital Reinvestment Ratio across 14 annual periods.
Annual Capital Reinvestment Ratio for Sang-A Frontec Co.Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for Sang-A Frontec Co.Ltd from 2011 to 2024. For live market cap and broader valuation context, see 089980 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.32x | ₩21.63 Billion | ₩28.49 Billion | ▲ +31.0% |
| 2023 | 1.01x | ₩28.67 Billion | ₩28.83 Billion | ▼ -44.7% |
| 2022 | 1.82x | ₩15.61 Billion | ₩28.38 Billion | ▼ -4.9% |
| 2021 | 1.91x | ₩20.86 Billion | ₩39.90 Billion | ▲ +63.0% |
| 2020 | 1.17x | ₩12.45 Billion | ₩14.61 Billion | ▼ -59.7% |
| 2019 | 2.91x | ₩3.51 Billion | ₩10.24 Billion | ▲ +103.7% |
| 2018 | 1.43x | ₩7.47 Billion | ₩10.68 Billion | ▲ +147.0% |
| 2017 | 0.58x | ₩25.21 Billion | ₩14.60 Billion | ▼ -90.4% |
| 2016 | 6.06x | ₩2.83 Billion | ₩17.15 Billion | ▲ +129.8% |
| 2015 | 2.64x | ₩9.15 Billion | ₩24.14 Billion | ▲ +44.2% |
| 2014 | 1.83x | ₩9.63 Billion | ₩17.61 Billion | ▲ +49.8% |
| 2013 | 1.22x | ₩13.55 Billion | ₩16.54 Billion | ▼ -16.3% |
| 2012 | 1.46x | ₩6.73 Billion | ₩9.81 Billion | ▼ -53.4% |
| 2011 | 3.13x | ₩6.06 Billion | ₩18.97 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow